The Effect of Iron Deficiency Anemia Treatment on Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio
DOI:
https://doi.org/10.15379/2408-9877.2016.03.01.01Keywords:
Iron deficiency, Anemia, Neutrophils, Lymphocytes, Platelets.Abstract
Background: Both neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) are cost-effective and readily available biomarkers. An increment in either NLR or PLR is an indicative of a prolonged chronic inflammatory condition and increased host inflammatory response. Iron deficiency anemia (IDA) is frequently associated in chronic disorders.
Aims: We decided to investigate whether the efficient treatment of IDA should affect NLR and/or PLR values in an adult population with IDA.
Methods: This was a retrospective (case-series) observational study conducted at an adult Hematology clinic in Turkey. Patients were ? 18 years-old, with IDA defined according to the World Health Organisation criteria. The hematological parameters, NLR, and PLR levels were noted before and after oral iron (Fe+2) repletion treatment.
Results: A total of 200 patients with IDA (median age 44 years, IQR 32-52 years, women 91%) were included. NLR values did not differ significantly in terms of IDA treatment (2.07 vs. 2.01, p= .558). PLR levels were significantly decreased after IDA treatment (170.63 vs. 140.32, p< .001). The NLR and PLR were positively correlated (p= .01). A low-unremarkable inverse correlation between NLR, and serum iron levels (p= .024) and Tfsat (p= .038) was observed; a similar negative correlation was also observed between PLR, and serum iron (p= .002) and Tfsat (p= .013) levels.
Conclusion: The treatment of IDA did not affect NLR, whereas it was associated with significant decrease in PLR. The NLR and PLR were positively correlated. However, both the NLR and PLR were inversely correlated with serum iron and Tfsat levels.
References
Kassebaum NJ, Jasrasaria R, Naghavi M, Wulf SK, Johns N, Lozano R, et al. A systematic analysis of global anemia burden from 1990 to 2010. Blood 2014; 123: 615-24. http://dx.doi.org/10.1182/blood-2013-06-508325
Camaschella C. Iron-deficiency anemia. New Engl J Med 2015; 372: 1832-43. http://dx.doi.org/10.1056/NEJMra1401038
Park JJ, Jang HJ, Oh IY, Yoon CH, Suh JW, Cho YS, et al. Prognostic value of neutrophil to lymphocyte ratio in patients presenting with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol 2013; 111: 636-42. http://dx.doi.org/10.1016/j.amjcard.2012.11.012
Templeton AJ, McNamara MG, Šeruga B, Vera-Badillo FE, Aneja P, Oca?a A, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst 2014; 106: dju124. http://dx.doi.org/10.1093/jnci/dju124
Templeton AJ, Ace O, McNamara MG, Al-Mubarak M, Vera-Badillo FE, Hermanns T, et al. Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis. C http://dx.doi.org/10.1158/1055-9965.EPI-14-0146
World Health Organisation. Nutritional anemias: report of a WHO scientific group. World Health Organ Tech Rep Ser 1968; 405: 5-37.
Ernst E, Hammerschmidt DE, Bagge U, Matrai A and Dormandy JA. Leukocytes and the risk of ischaemic diseases. JAMA 1987; 257: 2318-24. http://dx.doi.org/10.1001/jama.1987.03390170074031
Singh K. Leukocyte counts in anaemia. Indian J Physiol Pharmacol 2010; 54: 85-8.
Ekiz C, Agaoglu L, Karakas Z, Gurel N and Yalcin I. The effect of iron deficiency anemia on the function of the immune system. Hematol J 2005; 5: 579-83. http://dx.doi.org/10.1038/sj.thj.6200574
Mullick S, Rusia U, Sikka M and Faridi MA. Impact of iron deficiency anemia on T lymphocytes & their subsets in children. Indian J Med Res 2006; 124: 647-54.
Kantola T, Klintrup K, Väyrynen JP, Vornanen J, Bloiqu R, Karhu T, et al. Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma. Br J Cancer 2012; 107: 1729-36. http://dx.doi.org/10.1038/bjc.2012.456
Jablo?ska E, Kiluk M, Markiewicz W, Piotrowski L, Grabowska Z and Jablo?ski J. TNF-alpha, IL-6 and their soluble receptor serum levels and secretion by neutrophils in cancer patients. Arch Immunol Ther Exp (Warsz) 2001; 49: 63-9.
Azap B, Jaglall N, Atallah JP, Lamet A, Raja-Surya V, Farah B, et al. Neutrophil-lymphocyte ratio as a predictor of adverse outcomes of acute pancreatitis. Pancreatology 2011; 11: 445-52. http://dx.doi.org/10.1159/000331494
Acarturk G, Acay A, Demir K, Ulu MH, Ahsen A and Yuksel S. Neutrophil-to-lymphocyte ratio in inflammatory bowel disease – as a new predictor of disease severity. Bratisl Lek Listy 2015; 116: 213-7. http://dx.doi.org/10.4149/bll_2015_041
Kwon HC, Kim SH, Oh SY, Lee S, Lee JH, Choi HJ, et al. Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer. Biomarkers 2012; 17: 216-22. http://dx.doi.org/10.3109/1354750X.2012.656705
Wagner DD. New links between inflammation and thrombosis. Arterioscler Thromb Vasc Biol 2005; 25: 1321-4. http://dx.doi.org/10.1161/01.ATV.0000166521.90532.44
Klinger MH, Jelkman W. Role of blood platelets in infection and inflammation. J Interferon Cytokine Res 2002; 22: 913-22. http://dx.doi.org/10.1089/10799900260286623
Dan K. Thrombocytosis in iron deficiency anemia. Intern Med 2005; 44: 1025-26. http://dx.doi.org/10.2169/internalmedicine.44.1025
Kulnigg Dabsch S, Schmid W, Howaldt S, Stein J, Mickisch O, Waldhör T, et al. Iron deficiency generates secondary thrombocytosis and platelet activation in IBD: The randomised, controlled thrombo VIT trial. Inflamm Bowel Dis 2013; 19: 1609-16. http://dx.doi.org/10.1097/mib.0b013e318281f4db
Ohsugi Y. Recent advances in immunopathophysiology of interleukin-6: an innovative therapeutic drug, tocilizumab (recombinant humanized anti-human interleukin-6 receptor antibody), unveils the myterious etiology of immune-mediated inflammatory diseases. Biol Pharm Bull 2007; 30: 2001-6. http://dx.doi.org/10.1248/bpb.30.2001
Imai T, Koike K, Kubo T, Kikuchi T, Amano Y, Takagi M, et al. Interleukin-6 supports human megakaryocytic proliferation and differentiation in vitro. Blood 1991; 78: 1969-74.
Evstatiev R, Bukaty A, Jimenez K, Kulnigg-Dabsch S, Surman L, Schmid W, et al. Iron deficiency alters mekacaryopoiesis and platelet phenotype independent of thrombopoietin. Am J Hematol 2014; 89: 524-9. http://dx.doi.org/10.1002/ajh.23682
Lopez A, Cacoub B, Macdougall IC and Peyrin-Biroulet L. Iron deficiency anemia. Lancet 2015 Aug 24. pii: S0140-6736(15)60865-0. [Epub ahead of print]
Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004; 113: 1271-6. http://dx.doi.org/10.1172/JCI200420945
Downloads
Published
Issue
Section
License
Policy for Journals/Articles with Open Access
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work
Policy for Journals / Manuscript with Paid Access
Authors who publish with this journal agree to the following terms:- Publisher retain copyright .
- Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work .